AR and prostate cancer: However, prostate cancers often relapse and progress to a stage termed as castration-resistant prostate cancers (CRPC) (67, 68), and the majority of these CRPCs still depend on the AR signaling for growth and progression (the AR addictiveness) (69, 70).